Genetic studies have shown that polymorphisms in β2AR are associated with higher risk for developing sporadic AD (Rosenberg et al, 2008; Yu et al, 2008), and genetic reduction in β2AR significantly mitigates tauopathy in vivo (Wisely et al, 2014). Here, ADRB2 is linked to tauopathy.